Anthem Biosciences Limited has informed the Exchange that Board of Directors at its meeting held on May 19, 2026, recommended Final Dividend of Rs. 2 per equity share.
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anthem Biosciences Limited's Board approved audited financial results for FY2026 ending March 31, 2026. Standalone revenue grew to Rs. 2,089.31 million from Rs. 1,840.65 million, while profit after tax increased to Rs. 5,701.64 million from Rs. 5,061.79 million. Annual EPS improved to Rs. 10.15 from Rs. 9.05. The Board recommended a final dividend of Rs. 2 per equity share (100% payout on face value of Rs. 2) for FY2026, subject to shareholder approval at the July 22, 2026 AGM. The record date for dividend is June 26, 2026. Additionally, 14,81,250 equity shares were allotted under the ESOP 2024 scheme, increasing paid-up capital to Rs. 1,12,63,90,202.
The company declared a 100% dividend payout on face value, signaling strong financial health. However, based on the IPO issue price of Rs. 570, the dividend yield is approximately 0.35%, which does not qualify as a high-yield signal. The growth in revenues and profits alongside the ESOP allotment indicates good operational performance.